Compound class:
Synthetic organic
Comment: Example 4 is a highly potent, small-molecule inhibitor of the PD-1/PD-L1 interaction that is claimed in patent WO2017202275A1 [1].
|
|
References |
1. Feng Z, Chen X, Zhang L, Yang Y, Laifangfang, Ji M, Zhou C, Zheng Y, Xue N, Li L. (2017)
Bromo benzyl ether derivative, preparation method therefor, and pharmaceutical composition and uses thereof =. Patent number: WO2017202275A1. Assignee: Institute of Pharmaceutical Research, Chinese Academy of Medical Sciences. Priority date: 23/05/2016. Publication date: 30/11/2017. |